Literature DB >> 27942366

Surveillance of Antibiotic-Resistant Bacteria in King Khalid Hospital, Hafr Al-Batin, Saudi Arabia, During 2013.

Sulaiman Ali Al Yousef1.   

Abstract

BACKGROUND: Research to understand and control the emergence and spread of antimicrobial resistance has become a public health priority.
OBJECTIVES: This study was conducted to study epidemiology and resistant pattern of bacteria causing infection in different King Khalid hospital units. PATIENTS AND METHODS: All samples were sent to the lab and routinely processed according to the standard microbiological procedures. Then, the cultures yielding growth were selected for the study. Identification and antibiotic susceptibility test for all clinical isolates were processed by using MicroScan instrumentation. A total of 428 clinical samples were collected within 8 months; out of them, 300 clinical isolates were subjected to validation test.
RESULTS: Escherichia coli, Klebsiella pneumonia, and Pseudomonas aeruginosa were the commonly identified Gram-negative bacteria. Staphylococcus aureus was the only identified Gram-positive bacterium. The most common infections were taken from the wounds (39.0%), urinary tract (32.3%), and bloodstream (17.8%). The most common antibiotic-resistant bacteria were found on female surgical ward (100%) followed by ICU (90.2%), and male surgical ward (88.2%). The overall results of antibiotic resistance were 100% for S. aureus, 93.3% K. pneumonia, 75.7 % E. coli, and 100% for P. aeruginosa. Staphylococcus aureus showed high resistance to ampicillin and linezolid (94.1%). High (86.95%) and full resistance (100%) against ampicillin were observed from E. coli and K. pneumonia, respectively. P. aeruginosa was fully resistant to 4 antibiotics of cefazoline, cefoxitin, tetracycline, and trimethoprim-sulfamethoxazole.
CONCLUSIONS: The study was useful in determining the risk factors and defining different hospital units which should be targeted for measures to prevent infection.

Entities:  

Keywords:  Clinical Wards; Escherichia coli; Klebsiella pneumonia; Pseudomonas aeruginosa; Resistance; Staphylococcus aureus

Year:  2016        PMID: 27942366      PMCID: PMC5136423          DOI: 10.5812/jjm.19552

Source DB:  PubMed          Journal:  Jundishapur J Microbiol        ISSN: 2008-3645            Impact factor:   0.747


  18 in total

Review 1.  Antimicrobial resistance in zoonotic enteric pathogens.

Authors:  F J Angulo; J A Nunnery; H D Bair
Journal:  Rev Sci Tech       Date:  2004-08       Impact factor: 1.181

2.  Antibiotic resistance among Gram-negative non-fermentative bacteria at a teaching hospital in Saudi Arabia.

Authors:  A T Eltahawy; R M Khalaf
Journal:  J Chemother       Date:  2001-06       Impact factor: 1.714

3.  Etiology and antibacterial susceptibility pattern of community-acquired bacterial ocular infections in a tertiary eye care hospital in south India.

Authors:  M Jayahar Bharathi; R Ramakrishnan; C Shivakumar; R Meenakshi; D Lionalraj
Journal:  Indian J Ophthalmol       Date:  2010 Nov-Dec       Impact factor: 1.848

4.  Assessment of pathogen occurrences and resistance profiles among infected patients in the intensive care unit: report from the SENTRY Antimicrobial Surveillance Program (North America, 2001).

Authors:  Jennifer M Streit; Ronald N Jones; Helio S Sader; Thomas R Fritsche
Journal:  Int J Antimicrob Agents       Date:  2004-08       Impact factor: 5.283

5.  National nosocomial infections surveillance system (NNIS): description of surveillance methods.

Authors:  T G Emori; D H Culver; T C Horan; W R Jarvis; J W White; D R Olson; S Banerjee; J R Edwards; W J Martone; R P Gaynes
Journal:  Am J Infect Control       Date:  1991-02       Impact factor: 2.918

6.  Nosocomial significant bacteriuria: prevalence and pattern of bacterial pathogens among children hospitalised for non-infective urinary tract disorders.

Authors:  W A Olowu; T G Oyetunji
Journal:  West Afr J Med       Date:  2003 Jan-Mar

Review 7.  Strategies to Prevent and Control the Emergence and Spread of Antimicrobial-Resistant Microorganisms in Hospitals. A challenge to hospital leadership.

Authors:  D A Goldmann; R A Weinstein; R P Wenzel; O C Tablan; R J Duma; R P Gaynes; J Schlosser; W J Martone
Journal:  JAMA       Date:  1996-01-17       Impact factor: 56.272

8.  Prevalence of antimicrobial-resistant bacteria isolated from older versus younger hospitalized adults: results of a two-centre study.

Authors:  Stephen G Weber; Ram R Miller; Eli N Perencevich; Jocelyn Tolentino; David Meltzer; David Pitrak; Jessina C McGregor; Greg A Sachs; Anthony D Harris; Jon P Furuno
Journal:  J Antimicrob Chemother       Date:  2009-09-24       Impact factor: 5.790

9.  Current status of antimicrobial resistance in Taiwan.

Authors:  Po-Ren Hsueh; Cheng-Yi Liu; Kwen-Tay Luh
Journal:  Emerg Infect Dis       Date:  2002-02       Impact factor: 6.883

10.  Antimicrobial drug use and resistance in Europe.

Authors:  Nienke van de Sande-Bruinsma; Hajo Grundmann; Didier Verloo; Edine Tiemersma; Jos Monen; Herman Goossens; Matus Ferech
Journal:  Emerg Infect Dis       Date:  2008-11       Impact factor: 6.883

View more
  4 in total

1.  Evaluating the Prevalence and the Risk Factors of Gram-Negative Multi-Drug Resistant Bacteria in Eastern Saudi Arabia.

Authors:  Aisha S Al Hamdan; Amal A Alghamdi; Ghada F Alyousif; Fatma A Hamza; Marwa M Shafey; Aisha M AlAmri; Abdulaziz A Sunki
Journal:  Infect Drug Resist       Date:  2022-02-17       Impact factor: 4.003

2.  High antimicrobial resistant rates among Gram-negative pathogens in intensive care units. A retrospective study at a tertiary care hospital in Southwest Saudi Arabia.

Authors:  Mutasim E Ibrahim
Journal:  Saudi Med J       Date:  2018-10       Impact factor: 1.484

3.  Surveillance of antibiotic resistance among uropathogens in Aljouf region northern Saudi Arabia.

Authors:  Ibrahim Taher; Abdulrahman Almaeen; Hassan Aljourfi; Eyad Bohassan; Ahmed Helmy; Eman El-Masry; Baraka Saleh; Nawaf Aljaber
Journal:  Iran J Microbiol       Date:  2019-12

4.  Antimicrobial resistance among GLASS pathogens in conflict and non-conflict affected settings in the Middle East: a systematic review.

Authors:  Claudia Truppa; Mahmoud N Abo-Shehada
Journal:  BMC Infect Dis       Date:  2020-12-09       Impact factor: 3.667

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.